Frontiers in Endocrinology
AI-assisted segmentation-based fusion model integrating deep learning, radiomics, and clinical parameters for identifying coronary heart disease risk in patients with MAFLD
Cohort study of 1,515 peopleBiomarkers
Declared no competing interests
- Deep learning
- Machine learning
- Coronary artery disease
- Coronary heart disease
- Metabolic dysfunction-associated fatty liver disease
- Humans
The paper
Huzhou Normal University; Fourth People’s Hospital of Jinan
Frontiers in Endocrinology, 7 Aug 2026
